johnson and johnson glp-1 Readout Newsletter: & Johnson, Pfizer's GLP-1, more S6.E8: My Life on GLP1:

Target range is the upper-normal or slightly above reference range

Food intake questionnaires showed caloric reduction, but the magnitude of weight loss was greater than predicted by energy intake reduction using standard metabolic equations

Nausea, diarrhea, and constipation affect significant portions of the user population, and BPC-157 offers a direct countermeasure

FDA-approved GLP-1 peptides such as semaglutide and tirzepatide have the strongest safety data, with GoodRx confirming these prescription-only medications are safe and effective when used as directed, a status consistent with the FDA's approval of tirzepatide for chronic weight management

Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation

Of those, roughly 1 in 5 had an active GLP-1 prescription